Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-008971
Filing Date
2021-08-16
Accepted
2021-08-16 09:01:33
Documents
33
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mymx_10q.htm   iXBRL 10-Q 598084
2 CHANGES IN REGISTRANT CERTIFYING ACCOUNTANT mymx_ex161.htm EX-16.1 4658
3 CERTIFICATION mymx_ex311.htm EX-31.1 9231
4 CERTIFICATION mymx_ex312.htm EX-31.2 8999
5 CERTIFICATE mymx_ex32.htm EX-32 2843
  Complete submission text file 0001654954-21-008971.txt   3006848

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mmex-20210630.xsd EX-101.SCH 26530
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mmex-20210630_cal.xml EX-101.CAL 28656
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mmex-20210630_def.xml EX-101.DEF 56705
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mmex-20210630_lab.xml EX-101.LAB 164103
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mmex-20210630_pre.xml EX-101.PRE 126497
11 EXTRACTED XBRL INSTANCE DOCUMENT mymx_10q_htm.xml XML 582412
Mailing Address EUROPEAN EXECUTIVE OFFICE 4, ROUTE DE LA CORNICHE EPALINGES V8 CH-1066
Business Address EUROPEAN EXECUTIVE OFFICE 4, ROUTE DE LA CORNICHE EPALINGES V8 CH-1066 011-41-21-653-45-35
MYMETICS CORP (Filer) CIK: 0000927761 (see all company filings)

EIN.: 251741849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25132 | Film No.: 211174846
SIC: 2836 Biological Products, (No Diagnostic Substances)